GE11

• UNSPSC Description:

  GE11 is a active peptide and combines with colloidal drug delivery systems as smart carriers for antitumor drugs and can be used for cancer study[1].

• Target Antigen:

  Others

• Type:

  Peptides

• Related Pathways:

  Others

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/ge11.html

• Purity:

  99.93

• Solubility:

  H2O : 10 mg/mL (ultrasonic;warming)|DMSO : 20 mg/mL (ultrasonic;warming)

• Smiles:

  OC(C=C1)=CC=C1C[C@H](N)C(N[C@@H](CC2=CN=CN2)C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@@H]([C@H](O)C)C(N3[C@@H](CCC3)C(N[C@@H](CCC(N)=O)C(N[C@@H](CC(N)=O)C(N[C@@H](C(C)C)C(N[C@H](C(O)=O)[C@@H](C)CC)=O)=O)=O)=O)=O)=O)CC4=CC=C(C=C4)O)=O)=O)CC5=CC=C(C=C5)O)=O)CC6=CNC7=CC=CC=C67)=O)=O

• Molecular Weight:

  1540.68

• References & Citations:

  [1]Genta I, et al. GE11 Peptide as an Active Targeting Agent in Antitumor Therapy: A Minireview. Pharmaceutics. 2017;10(1):2. Published 2017 Dec 22.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

• Clinical Information:

  No Development Reported

• CAS Number:

  875142-25-9